Adamantane

CAS No. 281-23-2

Adamantane( —— )

Catalog No. M20336 CAS No. 281-23-2

The adamantane moiety is the structural backbone of numerous compounds and the physicochemical and biological properties of organic polyhedral compounds with practical application in the pharmaceutical industry.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 35 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Adamantane
  • Note
    Research use only, not for human use.
  • Brief Description
    The adamantane moiety is the structural backbone of numerous compounds and the physicochemical and biological properties of organic polyhedral compounds with practical application in the pharmaceutical industry.
  • Description
    The adamantane moiety is the structural backbone of numerous compounds and the physicochemical and biological properties of organic polyhedral compounds with practical application in the pharmaceutical industry.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    281-23-2
  • Formula Weight
    136.23
  • Molecular Formula
    C10H16
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 2 mg/mL (14.68 mM)
  • SMILES
    C1C2CC3CC1CC(C2)C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kuca K Windisch M Soukup O et al. Adamantane a?? A Lead Structure for Drugs in Clinical Practice[J]. Current Medicinal Chemistry 2016 23(29):-.
molnova catalog
related products
  • (20R)-Ginsenoside Rh...

    20S, 20R ginsenoside-Rh1 can inhibit the thrombin-induced conversion of fibrinogen to fibrin.

  • ACBI3

    ACBI3 (compound 7), a pan-KRAS degrader, effectively accomplishes the in vivo degradation of oncogenic KRAS .

  • LL-37 (37-1)

    LL-37 (37-1) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.